Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma

Extravasation can present serious accidental complication of intravenous drug application. While monoclonal antibodies do not show the necrotic potential of cytotoxic chemotherapy drugs, considerable inflammatory toxicity can occur, necessitating standardized operating procedures for the management...

Full description

Bibliographic Details
Main Authors: Michael Launspach, Marita Seif, Theresa M. Thole, Patrick Jesse, Joachim Schulz, Johannes H. Schulte, Susan Bischoff, Angelika Eggert, Hedwig E. Deubzer
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Children
Subjects:
cancer
immunotherapy
monoclonal antibody
soft tissue
inflammation
Online Access:https://www.mdpi.com/2227-9067/8/2/91

Internet

https://www.mdpi.com/2227-9067/8/2/91

Similar Items